SGLT2 & GLP-1 in Diabetes
Medical
Free · Designed for iPad
This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
Ratings & Reviews
This app hasn’t received enough ratings or reviews to display an overview.
Updated application to handle screens with notches better.
The developer, Med Learning Group, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy .
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- UMA MLG, LLC
- Size
- 194.7 MB
- Category
- Medical
- Compatibility
Requires iOS 11.0 or later.
- iPhone
Requires iOS 11.0 or later. - iPad
Requires iPadOS 11.0 or later. - iPod touch
Requires iOS 11.0 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- Copyright
- © 2019 UMA MLG, LLC